Translocation (10;11)(p12;q23) in childhood acute myeloid leukemia: incidence and complex mechanism

Cancer Genetics and Cytogenetics

Volumn 169, Issue 2, 2006, Pages 114-120

  Stasevich, Irina ^a   Utskevich, Regina ^a   Kustanovich, Anatoly ^a   Litvinko, Natallia ^a   Savitskaya, Tatsiana ^a   Chernyavskaya, Svetlana ^a   Saharova, Olga ^a   Aleinikova, Olga ^a  

^a Belarusian Research Center for Pediatric Oncology and Hematology   (Belarus)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CANCER PATIENT; CANCER SURVIVAL; CHILD; CHILDHOOD LEUKEMIA; CHROMOSOME 10P; CHROMOSOME 11Q; CHROMOSOME INSERTION; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION 10; CHROMOSOME TRANSLOCATION 11; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOGENETICS; DISEASE FREE SURVIVAL; FEMALE; HUMAN; HUMAN CELL; INFANT; MALE; PRIORITY JOURNAL; PROGNOSIS;

ACUTE DISEASE; ADOLESCENT; CHILD; CHILD, PRESCHOOL; CHROMOSOME BANDING; CHROMOSOMES, HUMAN, PAIR 10; CHROMOSOMES, HUMAN, PAIR 11; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INFANT; KARYOTYPING; LEUKEMIA, MYELOID; MALE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSLOCATION, GENETIC;

EID: 33747820211     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2006.03.011     Document Type: Article

References (33)

1. Arnaud B., Douet-Guilbert N., Morel F., Le Bris M., Herry A., Banzakour S., Bourquard P., Morice P., Le Calvez G., Marion V., Abgrall J., Berthou B., and Braekeleer M. Screening by fluorescence in situ hybridization for MLL status at diagnosis in 239 unselected patients with acute myeloblastic leukemia. Cancer Genet Cytogenet 161 (2005) 110-115
2. Hilden J.M., Smith F.O., Frestedt J.L., McGlennen R., Howells W.B., Sorensen P.H.B., Arthur D.C., Woods W.G., Buckley J., Bernstein I.D., and Kersey J.H. MLL gene rearrangement, cytogenetic 11q23 abnormalities, and expression of the NG2 molecule in infant acute myeloid leukemia. Blood 89 (1997) 3801-3805
3. Archimbaud E., Charrin C., Magaud J.-P., Campos L., Thomas X., Fière D., and Rimokh R. Clinical and biological characteristics of adult de novo and secondary acute myeloid leukemia with balanced 11q23 chromosomal anomaly or MLL gene rearrangement compared to cases with unbalanced 11q23 anomaly: confirmation of the existence of different entities with 11q23 breakpoint. Leukemia 12 (1998) 25-33
4. Cox M.C., Panetta P., Lo-Coco F., Del Poeta G., Venditti A., Maurillo L., Del Principe M.I., Mauriello A., Anemona L., Bruno A., Mazzone C., Palombo P., and Amadori S. Chromosomal aberration of the 11q23 locus in acute leukemia and frequency of MLL gene translocation. Am J Clin Pathol 122 (2004) 298-306
5. Mitelman F, Johansson B, Mertens F, editors. Catalog of chromosome abnormalities in cancer. 6th ed. [last print edition; updates available at: http://cgap.nci.nih.gov/Chromosomes/Mitelman]. New York: Wiley-Liss, 1998.
6. DiMartino J.F., and Cleary M.L. MLL rearrangements in haematological malignancies: lessons from clinical and biological studies. Br J Haematol 106 (1999) 614-626
7. Beverloo H.B., Le Coniat M., Wijsman J., Lillington D.M., Bernard O., de Klein A., van Wering E., Welborn J., Young B.D., Hagemeijer A., et al. Breakpoint heterogeneity in t(10;11) translocation in AML-M4/M5 resulting in fusion of AF10 and MLL is resolved by fluorescent in situ hybridization analysis. Cancer Res 55 (1995) 4220-4224
8. Fröhling S., Skelin S., Liebisch C., Scholl C., Schlenk R.F., Döhner H., and Döhner K. Comparison of cytogenetic and molecular cytogenetic detection of chromosome abnormalities in 240 consecutive adult patients with acute myeloid leukemia. J Clin Oncol 20 (2002) 2480-2485
9. Bennett J.M., Catovsky D., Daniel M.T., Flandrin G., Galton D.A., Gralnick H.R., Sultan C., and FAB Cooperative Group. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. Ann Intern Med 103 (1985) 620-625
10. ISCN 1995: an international system for human cytogenetic nomenclature (1995). In: Mitelman F. (Ed) (1995), S. Karger, Basel
11. Chomczynski P., and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem (1987) 156-162
12. Aleinikova OV, Maschan AA, Litvinko NP, Novichkova GA, Strongin US, Schneider MM. Preliminary results of treatment of childhood acute myeloid leukemia according to the protocol AML-MM-2000. In: Actual Problems of Pediatric Oncology and Hematology: Proceedings of the International Symposium. 8th ed. Minsk: Belarussian Center of Scientific Information; 2000, pp. 8-16.
13. Mecucci C., Rosati R., and La Starza R. Genetic profile of acute myeloid leukemia. Rev Clin Exp Hematol 61 (2002) 3-25
14. Raimondi S.C., Chang M.N., Ravindranath Y., Behm F.G., Gresik M.V., Steuber C.P., Weinstein H.J., and Caroll A.J. Chromosomal abnormalities in 478 children with acute myeloid leukemia: clinical characteristics and treatment outcome in cooperative pediatric oncology group study-POG 8821. Blood 94 (1999) 3707-3716
15. Mrózek K., Heerema N.A., and Bloomfield C.D. Cytogenetics in acute leukemia. Blood Rev 18 (2004) 115-136
16. Felix C.A., and Lance B.J. Leukemia in infants. Oncologist 4 (1999) 225-240
17. Chessells J.M., Harrison C.J., Kempski H., Webb D.K.H., Wheatley K., Hann I.M., Stevens R.F., Harrison G., and Gibson B.E. MRC Childhood Leukaemia Working Party. Clinical features, cytogenetics and outcome in acute lymphoblastic and myeloid leukaemia of infancy: report from the MRC Childhood Leukaemia working party. Leukemia 16 (2002) 776-784
18. Hayashi Y. The molecular genetics of recurring chromosome abnormalities in acute myeloid leukemia. Semin Hematol 37 (2000) 368-380
19. Roll P., Zattara-Cannoni H., Bustos-Bernard M., Curtillet C., Michel G., and Vagner-Capodano A. Molecular and fluorescence in situ hybridization analysis of a 10;11 rearrangement in a case of infant acute monocytic leukemia. Cancer Genet Cytogenet 135 (2002) 187-191
20. Van Limbergen H., Poppe B., Janssens A., De Bock R., De Pepe A., Noens L., and Spelman F. Molecular cytogenetic analysis of 10;11 rearrangements in acute myeloid leukemia. Leukemia 16 (2002) 344-351
21. Lillington D.M., Young B.D., Berger R., Martineau M., Moorman A.V., and Secker-Walker L.M. European 11q23 Workshop participants. The t(10;11)(p12;q23) translocation in acute leukemia: a cytogenetic and clinical study of 20 patients. Leukemia 12 (1998) 801-804
22. Chaplin T., Bernard O., Beverloo H.B., Saha V., Hagemeijer A., Berger R., and Young B.D. The t(10;11) translocation in acute myeloid leukemia (M5) consistently fuses the leucine zipper motif of AF10 onto the HRX gene. Blood 86 (1995) 2073-2076
23. Young B.D. Cytogenetic and molecular analysis of chromosome 11q23 abnormalities in leukaemia. Baillieres Clin Haematol 4 (1992) 881-895
24. DiMartino J.F., Ayton P.M., Chen E.H., Naftzger C.C., Young B.D., and Cleary M.L. The AF10 leucine zipper is required for leukemic transformation of myeloid progenitors by MLL-AF10. Blood 99 (2002) 3780-3785
25. Li Z.-Y., Liu D.-P., and Liang C.-C. New insight into the molecular mechanisms of MLL-associated leukemia. Leukemia 19 (2005) 183-190
26. Klaus M., Schnittger S., Haferlach T., Dreyling M., Hiddemann W., and Schoch C. Cytogenetics, fluorescence in situ hybridization, and reverse transcriptase polymerase chain reaction are necessary to clarify the various mechanisms leading to an MLL-AF10 fusion in acute myelocytic leukemia with 10;11 rearrangement. Cancer Genet Cytogenet 144 (2003) 36-43
27. Morerio C., Rapella A., Rosanda C., Lanino E., Nigro L., Cataldo A., Maserati E., Pasquali F., and Panarello C. MLL-MLLT10 fusion in acute monoblastic leukemia: variant complex rearrangements and 11q proximal breakpoint heterogeneity. Cancer Genet Cytogenet 152 (2004) 108-112
28. Dyson M.J., Talley P.J., Reilly J.T., Stevenson D., Parsons E., and Tighe J. Detection of cryptic MLL insertions using a commercial dual-color fluorescence in situ hybridization probe. Cancer Genet Cytogenet 147 (2003) 81-83
29. Dessen P, Huret JL. Chromosome 11 [Internet]. Atlas Genet Cytogenet Oncol Haematol 2002. Available at: http://www.infobiogen.fr/services/chromcancer/Indexbychrom/idxa_11.html. Accessed October 16, 2005.
30. Gamerdinger U., Teigler-Schlegel A., Pils S., Bruch J., Viehmann S., Keller M., Jauch A., and Harbott J. Cryptic chromosomal aberrations leading to an AML1/ETO rearrangement are frequently caused by small insertions. Genes Chromosomes Cancer 36 (2003) 261-272
31. Watanabe N., Kobayashi H., Ichiji O., Yoshiba M.A., Kikuta A., Komada Y., Sekine I., Ishida Y., Horiukoshi Y., Tsunematsu Y., Yano M., Nakadate H., and Kaneko Y. Cryptic insertion and translocation or nondividing leukemic cells disclosed by FISH analysis in infants acute leukemia with discrepant molecular and cytogenetic findings. Leukemia 17 (2003) 876-882
32. Casillas J.N., Woods W.G., Hunger S.P., McGavran L., Alonzo T.A., Feig S.A., and Children's Cancer Group. Prognostic implications of (10;11) translocations in childhood acute myelogenous leukemia: a report from the Children's Cancer Group. J Pediatr Hematol Oncol 25 (2003) 594-600
33. Dreyling M.H., Schrader K., Fonatsch C., Schlegelberger B., Haase D., Schoch C., Ludwig W.-D., Löffler H., Büchner T., Wörmann B., Hiddemann W., and Bohlander S.K. MLL and CALM are fused to AF10 in morphologically distinct subsets of acute leukemia with translocation t(10;11): both rearrangements are associated with a poor prognosis. Blood 91 (1998) 4662-4667